Health Technology

Pelago Announces Launch of Contingency Management Program

Retrieved on: 
Tuesday, April 9, 2024
Mental Health, Health, Technology, Health Technology, Other Health, General Health, Reward, ROI, Motivation, SAMHSA, Suds, Tobacco, Systematic review, Glasner, Multimedia, Substance Abuse, Economics, Meta-analysis

Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.

Key Points: 
  • Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.
  • With the introduction of this evidence-based treatment program, Pelago becomes the first nationwide digital substance use management provider to offer contingency management (CM), which will be incorporated into its comprehensive substance use disorder (SUDs) treatment offerings.
  • An earlier meta-analysis found that contingency management resulted in successful treatment episodes 61% of the time compared to 39% for other modalities.
  • For more information on how our contingency management program could benefit your population, visit www.pelagohealth.com Or contact a member of our team .

InfoBionic Rebrands Company Name to ‘InfoBionic.Ai’, Reinforcing Focus on AI-Enabled ECG

Retrieved on: 
Tuesday, April 9, 2024
Technology, Medical Devices, Health Technology, Telemedicine, Virtual Medicine, Cardiology, Software, Other Health, General Health, Health, Artificial Intelligence, Intelligence, ARC, Machine learning, Mayo Clinic, FDA, Heart, ECG, AI, Medical device

InfoBionic has always been dedicated to remaining at the cutting edge of patient care.

Key Points: 
  • InfoBionic has always been dedicated to remaining at the cutting edge of patient care.
  • Since the organization’s inception in 2015, AI and machine learning have been an integral part of InfoBionic’s remote cardiac telemetry offering.
  • In reality, this name change is just formalizing what we have already become,” says Stuart Long, CEO of InfoBionic.Ai.
  • “Our commitment to evolving remote cardiac telemetry monitoring through existing and novel AI-enabled ECG remains steadfast and unwavering.

The API Innovation Center, Apertus Pharmaceuticals Bring API Production of Critical Generic Cancer Drug to U.S. Soil

Retrieved on: 
Tuesday, April 9, 2024
Manufacturing, Retail, White House, Federal Government, Pharmaceutical, Research, Oncology, Supply Chain Management, Foundation, Science, Philanthropy, Public Policy, Government, Clinical Trials, General Health, Biotechnology, Health, Healthcare Reform, Health Technology, Chemicals, Plastics, Growth, Medication, Environment, Partnership, Lomustine, Patient, Pharmacy, Economic development, Cancer, Glioblastoma, Investment, API, Soil, Pharmaceutical industry

“Apertus Pharmaceuticals is proud to be selected as the contract manufacturer for lomustine,” said David Gindelberger, president and chief scientific officer of Apertus Pharmaceuticals.

Key Points: 
  • “Apertus Pharmaceuticals is proud to be selected as the contract manufacturer for lomustine,” said David Gindelberger, president and chief scientific officer of Apertus Pharmaceuticals.
  • "The St. Louis region is at the forefront of emerging technologies and API production,” said Sen. Brian Williams, D- St. Louis.
  • In 2023, the API Innovation Center was awarded $9.5 million from the Missouri Technology Corporation’s Advanced Manufacturing Resiliency Grant Program.
  • With this support, the API Innovation Center is investing in building a regional hub for drug advanced manufacturing, establishing Missouri as a leader in domestic API production to secure the U.S. essential drug supply chain.

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

Retrieved on: 
Tuesday, April 9, 2024
Technology, Medical Devices, Health Technology, Cardiology, Software, Biotechnology, Health, Data Management, Artificial Intelligence, Algorithm, Atrial flutter, Intelligence, Patient, Doctor of Philosophy, MD, Arrhythmia, Vectorcardiography, FDA, VCG, ECG, Medical device

This marks the first scientific presentation on the company’s deep learning algorithm, HeartBeam AI.

Key Points: 
  • This marks the first scientific presentation on the company’s deep learning algorithm, HeartBeam AI.
  • The technology is designed to be used in HeartBeam’s small, portable, patient-friendly devices that allow for remote cardiac monitoring.
  • HeartBeam believes this presents a unique opportunity to create a comprehensive repository of data that could unlock personalized AI-driven insights to improve cardiac care.
  • “As we continue to expand our artificial intelligence capabilities, we look forward to demonstrating how the combination of our data rich 3D VECG platform with HeartBeam AI has the potential to transform how cardiac health is managed in the future.”

New Study Finds AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration and Significantly Reduce False Alarms for Clinicians

Retrieved on: 
Tuesday, April 9, 2024
Software, Telemedicine, Virtual Medicine, Health, FDA, Artificial Intelligence, Medical Devices, Health Technology, Technology, Hospital, UMass Memorial Health, Data science, Caregiver, Risk, CLEW, Journal, Mortality, Intensive care unit, Telehealth, MD, Respiratory failure, Critical care, WakeMed, Nursing care plan, Fatigue, ICU

The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.

Key Points: 
  • The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.
  • It also supports the health system with capacity management, by providing early identification of potential bottlenecks caused by unexpected deterioration.
  • In addition to demonstrating its superior accuracy, the study concluded that the CLEW system generated 50-times fewer alarms than other leading systems.
  • In busy and overburdened critical care environments, this can greatly reduce alarm fatigue and the associated cognitive burden on caregivers.

OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Technology, Other Health, Health, General Health, Pharmaceutical, Health Technology, Research, Artificial Intelligence, Surgery, Science, University Challenge 2013–14, Partnership, Physician, Inflammation, Patient, American Academy, Standard of care, CRS, AI, Medtronic, PROPEL, ENT, Sinusitis, ESS, Adhesion, Pharmaceutical industry

The study focused on healthcare resource use (HCRU) and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent endoscopic sinus surgery (ESS).

Key Points: 
  • The study focused on healthcare resource use (HCRU) and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent endoscopic sinus surgery (ESS).
  • The study found that PROPEL devices are associated with lower HCRU and revision surgery during a 24-month follow-up period after ESS.
  • Thus, the use of PROPEL devices may lead to payer savings from reduced healthcare resource utilization.
  • “The results of this study demonstrate a rare win-win-win within healthcare,” said Amy Van Sach, president of Medtronic ENT.

Q Bio Unveils New MRI Technology - Tensor Field Mapping - Advancing Measurement in Medical Imaging

Retrieved on: 
Tuesday, April 9, 2024
Medical Devices, Health, Technology, Health Technology, Artificial Intelligence, Diagnosis, Physics, Benchmarking, GPU, MRI, Magnetic resonance imaging, Patient, Tissue, Research, AI, Software, TFM, Magnetic resonance, Medical imaging

Q Bio Inc. , an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM) , a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable.

Key Points: 
  • Q Bio Inc. , an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM) , a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable.
  • "Tensor Field Mapping is more than an innovative technology; it's a vision for the future of medical imaging where frequency, accuracy, and benchmarking with commodity radiomic data is possible," added Clarissa Shen, COO, Q Bio.
  • Q Bio Inc. is committed to advancing medical imaging technology and improving patient outcomes.
  • With the launch of Tensor Field Mapping, the company is at the forefront of a new era in diagnostics and personalized medicine.

I-PASS Appoints Healthcare Leader and Patient Safety Expert Patricia McGaffigan to Its Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
Nursing, Health, Hospitals, Practice Management, Health Technology, Managed Care, General Health, CPPS, Communication, McGaffigan, University, Senior, Critical care, National Patient Safety Foundation, Workforce, Approximation error, IHI, Patient safety

With extensive experience spanning clinical practice, academia, medical technology innovation, and nonprofit leadership, McGaffigan brings an invaluable depth of healthcare leadership and patient safety expertise to the I-PASS board.

Key Points: 
  • With extensive experience spanning clinical practice, academia, medical technology innovation, and nonprofit leadership, McGaffigan brings an invaluable depth of healthcare leadership and patient safety expertise to the I-PASS board.
  • McGaffigan currently serves as the President of the Certification Board for Professionals in Patient Safety and Vice President of Safety at the Institute for Healthcare Improvement (IHI) and serves as senior sponsor for the IHI’s Lucian Leape Institute and co-chair of the National Steering Committee for Patient Safety.
  • “Advancing the safety and quality of patient care has been the cornerstone of my career for the past four decades,” said McGaffigan.
  • “As a veteran of patient safety and a distinguished healthcare leader, Patricia brings an unparalleled passion for improving the safety and quality of patient care across the healthcare continuum,” said William Floyd, CEO of the I-PASS Patient Safety Institute.

Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists

Retrieved on: 
Tuesday, April 9, 2024
Technology, Biotechnology, Health, Other Health, Pharmaceutical, Artificial Intelligence, Oncology, Practice Management, Software, Managed Care, General Health, Health Technology, Data Management, Clinical Trials, Cloud, Diagnosis, Google Cloud, Organization, Face, Medicine, Radiology, Drug discovery, Partnership, Ideation, Bias, BigQuery, Patient, Chronicle, Health care, Artificial intelligence, AI, Workload, Medical device

Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.

Key Points: 
  • Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.
  • As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud’s technology, including its generative AI (gen AI) tools.
  • The platform is built on Google Cloud and uses tools like Vertex AI, BigQuery, Healthcare API and Chronicle.
  • Bayer and Google Cloud are also working together to transform patient care worldwide through responsible AI adoption.

Atlantic Health System Adopts FeelBetter’s Precision Population Health Platform to Optimize and Personalize Medication Management

Retrieved on: 
Tuesday, April 9, 2024
Health, Technology, Practice Management, Health Technology, General Health, Artificial Intelligence, Pharmaceutical, Diagnosis, ACO, Atlantic Ocean, Entrepreneurship, Acos, Atlantic Health System, Partnership, Physician, Patient, AI, Death, Quality of life, Pharmacology, Polypharmacy, Medicare, Hospital, Nursing

FeelBetter , the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a commercial partnership with Atlantic Health System (“Atlantic Health”).

Key Points: 
  • FeelBetter , the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a commercial partnership with Atlantic Health System (“Atlantic Health”).
  • The not-for-profit health system, which provides care for more than half the state of New Jersey and parts of New York and Pennsylvania, is leveraging FeelBetter’s AI-based precision population health platform to optimize and personalize medication management for polypharmacy patients across Atlantic Health System aligned Accountable Care Organizations (ACO).
  • “At Atlantic Health System, adopting new AI-based technologies with the potential to enhance healthcare is part of our unwavering commitment to providing high quality, safe, affordable patient care,” said Dr. Thomas Kloos, President, Vice President, Atlantic Health System and President, Atlantic Accountable Care Organization.
  • In the US alone, every year, suboptimal medication management results in 275,000 deaths and more than $528B in avoidable costs .